P A Speth

1.0k total citations
24 papers, 861 citations indexed

About

P A Speth is a scholar working on Oncology, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, P A Speth has authored 24 papers receiving a total of 861 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 9 papers in Cardiology and Cardiovascular Medicine and 7 papers in Molecular Biology. Recurrent topics in P A Speth's work include Chemotherapy-induced cardiotoxicity and mitigation (9 papers), Cancer therapeutics and mechanisms (5 papers) and Cancer Treatment and Pharmacology (4 papers). P A Speth is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (9 papers), Cancer therapeutics and mechanisms (5 papers) and Cancer Treatment and Pharmacology (4 papers). P A Speth collaborates with scholars based in Netherlands, United States and India. P A Speth's co-authors include C. Haanen, Q.G.C.M. van Hoesel, P. Linssen, H. Wessels, J.B.M. Boezeman, Timothy J. Kinsella, C. B. H. W. Lamers, Jerry M. Collins, Alfred E. Chang and R. S. G. Holdrinet and has published in prestigious journals such as Journal of Clinical Oncology, Gut and British Journal of Cancer.

In The Last Decade

P A Speth

24 papers receiving 819 citations

Peers

Countries citing papers authored by P A Speth

Since Specialization

Citations

This map shows the geographic impact of P A Speth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P A Speth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P A Speth more than expected).

Fields of papers citing papers by P A Speth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P A Speth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P A Speth. The network helps show where P A Speth may publish in the future.

Co-authorship network of co-authors of P A Speth

This figure shows the co-authorship network connecting the top 25 collaborators of P A Speth. A scholar is included among the top collaborators of P A Speth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P A Speth. P A Speth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Generation-based Evolutionary Tool for the Optimization of Constellations (GenETOC) 2021 ·(unknown), (unknown), P. Kessler, P A Speth	1
2	In vivo and in vitro pharmacokinetic differences between four structurally closely related anthracyclines in hematopoietic cell subtypes in humans. 1989 ·Drug Metabolism and Disposition ·P A Speth, P. Linssen, E. F. S. Termond, J.B.M. Boezeman, H. Wessels, (unknown)	11
3	A phase I study of intraarterial iododeoxyuridine in patients with colorectal liver metastases. 1989 ·Journal of Clinical Oncology ·Alfred E. Chang, Jerry M. Collins, P A Speth, Ryan Smith, (unknown), (unknown), (unknown), Eli Glatstein, Timothy J. Kinsella	32
4	Iododeoxyuridine (IdUrd) incorporation into DNA of human hematopoietic cells, normal liver and hepatic metastases in man: As a radiosensitizer and as a marker for cell kinetic studies 1989 ·International Journal of Radiation OncologyBiologyPhysics ·P A Speth, Timothy J. Kinsella, Alfred E. Chang, Raymond W. Klecker, Karl Bélanger, (unknown), J. Mark Rowland, James Cupp, Jerry M. Collins	24
5	Clinical Pharmacokinetics of Doxorubicin 1988 ·Clinical Pharmacokinetics ·P A Speth, Q.G.C.M. van Hoesel, C. Haanen	351
6	Phase I and pharmacokinetic studies with the pentacyclic pyrroloquinone mitoquidone 1988 ·Cancer Chemotherapy and Pharmacology ·P A Speth, Martin Gore, (unknown), David R. Newell, (unknown), (unknown), John A. Green, Lindsey Gumbrell, P. Linssen, Antonius A. Miller, Ian E. Smith, J. G. McVie, P.H.M. de Mulder, B.E. de Pauw, (unknown), G.W. Brown	5
7	In vivo cellular adriamycin concentrations related to growth inhibition of normal and leukemic human bone marrow cells 1988 ·European Journal of Cancer and Clinical Oncology ·P A Speth, (unknown), J.B.M. Boezeman, P. Linssen, T.J.M. de Witte, H. Wessels, C. Haanen	20
8	Selective incorporation of iododeoxyuridine into DNA of hepatic metastases versus normal human liver 1988 ·Clinical Pharmacology & Therapeutics ·P A Speth, Timothy J. Kinsella, Alfred E. Chang, Raymond W. Klecker, Karl Bélanger, Jerry M. Collins	35
9	Fluorodeoxyuridine modulation of the incorporation of iododeoxyuridine into DNA of granulocytes: a phase I and clinical pharmacological study. 1988 ·PubMed ·P A Speth, Timothy J. Kinsella, K. Bélanger, R W Klecker, (unknown), (unknown), J. Michael Collins	21
10	Glucomannan prevents postprandial hypoglycaemia in patients with previous gastric surgery. 1988 ·Gut ·Wim P.M. Hopman, Philipp Houben, P A Speth, C. B. H. W. Lamers	22
11	Determination of amsacrine in human nucleated hematopoietic cells 1987 ·Journal of Chromatography B Biomedical Sciences and Applications ·Paul Brons, J.M.C. Wessels, P. Linssen, C. Haanen, P A Speth	8
12	Investigation of the Role of Mononuclear Phagocytes in the Transportation of Doxorubicin-Containing Liposomes Into a Solid Tumor 1987 ·PubMed ·G. Storm, (unknown), Peter A. Steerenberg, P A Speth, Frits H. Roerdink, Joke Regts, Marleen H. van der Veen, Wim H. de Jong	12
13	Propylene Glycol Pharmacokinetics and Effects after Intravenous Infusion in Humans 1987 ·Therapeutic Drug Monitoring ·P A Speth, T.B. Vree, (unknown), P.H.M. de Mulder, David R. Newell, M. Gore, B.E. de Pauw	53
14	Infusion-rate independent cellular adriamycin concentrations and cytotoxicity to human bone marrow clonogenic cells (CFU-GM) 1987 ·British Journal of Cancer ·(unknown), P A Speth, T. de Witte, P. Linssen, J. Wessels, C. Haanen	9
15	Improved flow cytometry of cellular DNA and RNA by on‐line reagent addition 1987 ·Cytometry ·(unknown), P A Speth, H. Wessels, C. Haanen	15
16	Cellular and plasma pharmacokinetics of weekly 20-mg 4?-epi-adriamycin bolus injection in patients with advanced breast carcinoma 1986 ·Cancer Chemotherapy and Pharmacology ·P A Speth, P. Linssen, L.V.A.M. Beex, J.B.M. Boezeman, C. Haanen	21
17	Rapid quantitative determination of four anthracyclines and their main metabolites in human nucleated haematopoietic cells 1986 ·Journal of Chromatography B Biomedical Sciences and Applications ·P A Speth, P. Linssen, J.B.M. Boezeman, J.M.C. Wessels, C. Haanen	16
18	Evaluation of lay skills in cardiopulmonary resuscitation. 1985 ·Heart ·(unknown), P A Speth, (unknown), J T Vonk	37
19	Quantitation of anthracyclines in human hematopoietic cell subpopulations by flow cytometry correlated with high pressure liquid chromatography 1985 ·Cytometry ·P A Speth, P. Linssen, J.B.M. Boezeman, H. Wessels, C. Haanen	33
20	Effect of acarbose, pectin, a combination of acarbose with pectin, and placebo on postprandial reactive hypoglycaemia after gastric surgery. 1983 ·Gut ·P A Speth, J.B.M.J. Jansen, C. B. H. W. Lamers	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact